Topiramate in the treatment of partial and generalized epilepsy

References

• Abou-KhalilB2000Topiramate in the long-term management of refractory epilepsy. Topiramate YOL Study GroupEpilepsia41Suppl 1S72610768305
   PubMedGoogle Scholar
• Albsoul-YounesAMSalemHAAjlouniSF2004Topiramate slow dose titration: improved efficacy and tolerabilityPediatr Neurol313495215519117
   PubMed Web of Science ®Google Scholar
• AldenkampAP2000Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adultsNeurology54271210636175
   PubMed Web of Science ®Google Scholar
• AldenkampAPBakerGAMulderOG2000A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizuresEpilepsia411167810999556
   PubMed Web of Science ®Google Scholar
• ArroyoSDodsonWEPriviteraMD2005Randomized dose-controlled study of topiramate as first-line therapy in epilepsyActa Neurol Scand1122142216146489
   PubMed Web of Science ®Google Scholar
• AykutluEBaykanBGursesC2005Add-on therapy with topiramate in progressive myoclonic epilepsyEpilepsy Behav6260315710314
   PubMed Web of Science ®Google Scholar
• Ben-MenachemEAxelsenMJohansonEH2003Predictors of weight loss in adults with topiramate-treated epilepsyObes Res115566212690085
   PubMedGoogle Scholar
• Ben-MenachemEHenriksenODamM1996Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizuresEpilepsia37539438641230
   PubMed Web of Science ®Google Scholar
• Ben-ZeevBWatembergNAugartenA2003Oligohydrosis and hyperthermia: pilot study of a novel topiramate adverse effectJ Child Neurol18254712760427
   PubMed Web of Science ®Google Scholar
• BialerMDooseDRMurthyB2004Pharmacokinetic interactions of topiramateClin Pharmacokinet437638015355124
   PubMed Web of Science ®Google Scholar
• BitonVBourgeoisBF2005Topiramate in patients with juvenile myoclonic epilepsyArch Neurol621705816286543
   PubMedGoogle Scholar
• BitonVEdwardsKRMontourisGD2001Topiramate titration and tolerabilityAnn Pharmacother35173911215835
   PubMed Web of Science ®Google Scholar
• BitonVMontourisGDRitterF1999A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study GroupNeurology521330710227614
   PubMed Web of Science ®Google Scholar
• BootsmaHPCoolenFAldenkampAP2004Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy centerEpilepsy Behav5380715145308
   PubMed Web of Science ®Google Scholar
• CerminaraCSeriSBombardieriR2006Hypohidrosis during topiramate treatment: a rare and reversible side effectPediatr Neurol34392416648001
   PubMed Web of Science ®Google Scholar
• CheungEWongVFungCW2005Topiramate-valproate-induced hyperammonemic encephalopathy syndrome: case reportJ Child Neurol201576015794187
   PubMed Web of Science ®Google Scholar
• ChristensenJAndreasenFPoulsenJH2003Randomized, concentration-controlled trial of topiramate in refractory focal epilepsyNeurology6112101814610122
   PubMed Web of Science ®Google Scholar
• CoppolaGCapovillaGMontagniniA2002Topiramate as add-on drug in severe myoclonic epilepsy in infancy: an Italian multicenter open trialEpilepsy Research4945811948006
   PubMed Web of Science ®Google Scholar
• CoulterDASombatiSDelorenzoRJ1993Selective effects of topiramate on sustained repetitive firing and spontaneous bursting in cultured hippocampal neuronsEpilepsia34123
   Google Scholar
• CrossJH2002Topiramate monotherapy for childhood absence seizures: an open-lable pilot studySeizure114061012160672
   PubMed Web of Science ®Google Scholar
• DodgsonSJShankRPMaryanoffBE2000Topiramate as an inhibitor of carbonic anhydrase isoenzymesEpilepsia41Suppl 1S35910768298
   PubMed Web of Science ®Google Scholar
• DodsonWEKaminMKrautL2003Topiramate titration to response: analysis of individualized therapy study (TRAITS)Epilepsia3761520
   Google Scholar
• DooseDRBrodieMJWilsonEA2003Topiramate and lamotrigine pharmacokinetics during repetitive monotherapy and combination therapy in epilepsy patientsEpilepsia449172212823574
   PubMed Web of Science ®Google Scholar
• DooseDRWalkerSAGisclonLG1996Single-dose pharmacokinetics and effect of food on the bioavailability of topiramate, a novel antiepileptic drugJ Clin Pharmacol36884918930774
   PubMed Web of Science ®Google Scholar
• DooseDRWangSSPadmanabhanM2003Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjectsEpilepsia44540912681003
   PubMed Web of Science ®Google Scholar
• EltermanRDGlauserTAWyllieE1999A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Topiramate YP Study GroupNeurology5213384410227615
   PubMed Web of Science ®Google Scholar
• FaughtE1999Clinical studies of topiramateDrugs Today (Barc)35495712973409
   PubMed Web of Science ®Google Scholar
• FaughtELimdiNEttingerABDevinskyO2002Adverse and beneficial side effects of antiepileptic drugsManaging epilepsy and co-existing disordersBostonButterworth-Heinemann
   Google Scholar
• FaughtEWilderBJRamsayRE1996Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Topiramate YD Study GroupNeurology461684908649570
   PubMed Web of Science ®Google Scholar
• FraunfelderFWFraunfelderFTKeatesEU2004Topiramate-associated acute, bilateral, secondary angle-closure glaucomaOphthalmology1111091114711721
   PubMed Web of Science ®Google Scholar
• GarrisSSOlesKS2005Impact of topiramate on serum bicarbonate concentrations in adultsAnnals Pharmacother394246
   PubMed Web of Science ®Google Scholar
• GilliamFVelosoFBomhofMA2003A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsyNeurology6019620212552030
   PubMed Web of Science ®Google Scholar
• GisclonLGRiffitsJMSicaDA1993The pharmacokinetics (PK) of topiramate (T) in subjects with renal impairment (RI) as compared to matched subjects with normal renal function (NRF)Pharmaceutical Research10S397
   Google Scholar
• GlauserTA1999TopiramateEpilepsia40Suppl 5S718010530697
   PubMed Web of Science ®Google Scholar
• GlauserTAClarkPOStrawsburgR1998A pilot study of topiramate in the treatment of infantile spasmsEpilepsia39132489860068
   PubMed Web of Science ®Google Scholar
• GrossoSGalimbertiDFarnetaniMA2005Efficacy and safety of topiramate in infants according to epilepsy syndromesSeizure14183915797353
   PubMed Web of Science ®Google Scholar
• GryderDSRogawskiMA2003Selective antagonism of GluR5 kainate-receptor-mediated synaptic currents by topiramate in rat basolateral amygdala neuronsJ Neuroscience23706974
   PubMed Web of Science ®Google Scholar
• GubermanANetoWGassman-MayerC2002Low-dose topiramate in adults with treatment-resistant partial-onset seizuresActa Neurol Scand106183912225311
   PubMed Web of Science ®Google Scholar
• GuerriniRCarpayJGroseljJ2005Topiramate monotherapy as broad-spectrum antiepileptic drug in a naturalistic clinical settingSeizure143718015961326
   PubMed Web of Science ®Google Scholar
• HamerHMKnakeSSchomburgU2000Valproate-induced hyper-ammonemic encephalopathy in the presence of topiramateNeurology54230210636156
   PubMed Web of Science ®Google Scholar
• HerreroAIDel OlmoNGonzalez-EscaladaJR2002Two new actions of topiramate: inhibition of depolarizing GABA(A)-mediated responses and activation of a potassium conductanceNeuropharmacology422102011804617
   PubMed Web of Science ®Google Scholar
• HosainSAMerchantSSolomonGE2006Topiramate for treatment of infantile spasmsJ Child Neurol21171916551447
   PubMed Web of Science ®Google Scholar
• JansenJAldenkampAPMajoieM2006Functional MEI reveals declined prefrontal cortex activation in patients with epilepsy on topiramate therapyEpilepsy Behav9181516793345
   PubMed Web of Science ®Google Scholar
• JohannessenSI1997Pharmacokinetics and interaction profile of topiramate: review and comparison with other newer antiepileptic drugsEpilepsia38Suppl 1S18239092953
   PubMed Web of Science ®Google Scholar
• KannerAWuuJFaughtE2003A past psychiatric history may be a risk factor for topiramate-related psychiatric and cognitive adverse eventsEpilepsy Behav45485214527497
   PubMed Web of Science ®Google Scholar
• KhanAFaughtEGilliamF1999Acute psychotic symptoms induced by topiramateSeizure8235710452922
   PubMed Web of Science ®Google Scholar
• KohSJensenFE2001Topiramate blocks perinatal hypoxia-induced seizures in rat pupsAnn Neurol503667211558793
   PubMed Web of Science ®Google Scholar
• Korean Topiramate Study Group1999Topiramate in medically intractable partial epilepsies: double-blind placebo-controlled randomized parallel group trialEpilepsia4017677410612342
   PubMed Web of Science ®Google Scholar
• KwanPBrodieM2000Early identification of refractory epilepsyN Engl J Med3423141910660394
   PubMed Web of Science ®Google Scholar
• LatourPBirabenAPolardE2004Drug induced encephalopathy in six epileptic patients: topiramate? valproate? or bothHum Psychopharmacol1919320315079854
   PubMed Web of Science ®Google Scholar
• LeeH-WJungD-KSuhC-K2006Cognitive effects of low-dose topiramate monotherapy in epilepsy patients: a 1-year follow-upEpilepsy Behav87364116647301
   PubMed Web of Science ®Google Scholar
• LhatooSDWongICPolizziG2000Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsyEpilepsia411592611114218
   PubMed Web of Science ®Google Scholar
• LoescherWSchmidtD2006Experimental and clinical evidence for loss of effect (tolerance) during prolonged treatment with antiepileptic drugsEpilepsia4712538416922870
   PubMed Web of Science ®Google Scholar
• LoftonALKlein-SchwartzW2005Evaluation of toxicity of topiramate exposures reported to poison centersHum Exp Toxicol24591516323576
   PubMed Web of Science ®Google Scholar
• LonginETeichMKoelfenW2002Topiramate enhances the risk of valproate-associated side effects in three childrenEpilepsia43451411952778
   PubMed Web of Science ®Google Scholar
• MajkowskiJNetoWWapenaarR2005Time course of adverse events in patients with localization-related epilepsy receiving topiramate added to carbamazepineEpilepsia466485315857429
   PubMed Web of Science ®Google Scholar
• MarsonAGAl-KharusiAMAlwaidhM2007aThe SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treamtent of partial epilepsy: an unblinded randomised controlled trialLancet36910001517382827
   PubMed Web of Science ®Google Scholar
• MarsonAGAl-KharusiAMAlwaidhM2007bThe SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trialLancet36910162617382828
   PubMed Web of Science ®Google Scholar
• MaryanoffBENorteySOGardockiJF1987Anticonvulsant O-alkyl sulfamates. 2, 3:4, 5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate and related compoundsJ Med Chem3088073572976
   PubMed Web of Science ®Google Scholar
• McleanMJBukhariAAWamilAW2000Effects of topiramate on sodium-dependent action-potential firing by mouse spinal cord neurons in cell cultureEpilepsia41Suppl 1S21410768295
   PubMed Web of Science ®Google Scholar
• MeadorKJLoringDWHulihanJF2003Differential cognitive and behavioral effects of topiramate and valproateNeurology601483812743236
   PubMed Web of Science ®Google Scholar
• MeadorKJLoringDWVahleVJ2005Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteersNeurology6421081415985582
   PubMed Web of Science ®Google Scholar
• MikaeloffYDe Saint-MartinAManciniJ2003Topiramate: efficacy and tolerability in children according to epilepsy syndromesEpilepsy Res532253212694931
   PubMed Web of Science ®Google Scholar
• MulaMTrimbleMRThompsonP2003Topiramate and wordfinding difficulties in patients with epilepsyNeurology601104712682314
   PubMed Web of Science ®Google Scholar
• NakatsukaTKomatsuTFujiiT1992Axial skeletal malformations induced by acetazolamide in rabbitsTeratology45629361412055
   PubMedGoogle Scholar
• NaritokuDKHulihanJFSchwarzmanLK2005Effect of cotherapy reduction on tolerability of epilepsy add-on therapy: a randomized controlled trialAnn Pharmacother394182315701778
   PubMed Web of Science ®Google Scholar
• Neurologics, Ortho-Mcneil Pharmaceutical Inc2006TOPAMAX prescribing information URL: http://www.topamax-epilepsy.com/utilities/images/tpamax.pdf#zoom=100
   Google Scholar
• NiebauerMGruenthalM1999Topiramate reduces neuronal injury after experimental status epilepticusBrain Res837263910434011
   PubMed Web of Science ®Google Scholar
• Nieto-BarreraMCandauRNieto-JimenezM2000Topiramate in the treatment of severe myoclonic epilepsy in infancySeizure9590411162758
   PubMed Web of Science ®Google Scholar
• PeruccaE1997A pharmacological and clinical review on topiramate, a new antiepileptic drugPharmacol Res35241569264038
   PubMed Web of Science ®Google Scholar
• PriviteraMFinchamRPenryJ1996Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Topiramate YE Study GroupNeurology461678838649569
   PubMed Web of Science ®Google Scholar
• PriviteraMDBrodieMJMattsonRH2003Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsyActa Neurol Scand1071657512614309
   PubMed Web of Science ®Google Scholar
• ReifeRPledgerGWuSC2000Topiramate as add-on therapy: pooled analysis of randomized controlled trials in adultsEpilepsia41Suppl 1S667110768304
   PubMedGoogle Scholar
• RigoulotMBoehrerANehligA2003Effects of topiramate in two models of genetically-determined generalized epilepsy, the GAERS and the audiogenic Wister ASEpilepsia44141912581224
   PubMed Web of Science ®Google Scholar
• RosenfeldWEDooseDRWalkerSA1999A study of topiramate pharmacokinetics and tolerability in children withh epilepsyPediatric Neurology203394410371378
   PubMed Web of Science ®Google Scholar
• RosenfeldWEDooseDRWalkerSA1997Effect of topiramate on the pharmacokinetics of an oral contraceptive containing noreth-indrone and ethinyl estradiol in patients with epilepsyEpilepsia38317239070594
   PubMed Web of Science ®Google Scholar
• RosenfeldWESlaterJ2002Characterization of topiramate-associated weight changes in adults with epilepsyEpilepsia43 Suppl 7220112121325
   PubMed Web of Science ®Google Scholar
• SachdeoRWassersteinAMesenbrinkP2002Effects of oxcarbazepine on sodium concentration and water handlingAnn Neurol516132012112108
   PubMed Web of Science ®Google Scholar
• SachdeoRCGlauserTARitterF1999A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study GroupNeurology521882710371538
   PubMed Web of Science ®Google Scholar
• SachdeoRCReifeRALimP1997Topiramate monotherapy for partial onset seizuresEpilepsia382943009070591
   PubMed Web of Science ®Google Scholar
• SachdeoRCSachdeoSKLevyRH2002Topiramate and phenytoin pharmacokinetics during repetitive monotherapy and combination therapy to epileptic patientsEpilepsia43691612102670
   PubMed Web of Science ®Google Scholar
• SachdeoRCSachdeoSKWalkerSA1996Steady-state pharmacokinetics of topiramate and carbamazepine in patients with epilepsy during monotherapy and concomitant therapyEpilepsia37774808764818
   PubMed Web of Science ®Google Scholar
• SchneidermanJH1998Topiramate: pharmacokinetics and pharmacodynamicsCan J Neurol Sci25S359706732
   PubMed Web of Science ®Google Scholar
• ShankRPGardockiJFStreeterAJ2000An overview of the pre-clinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of actionEpilepsia41Suppl 1S3910768292
   PubMed Web of Science ®Google Scholar
• ShankRPGardockiJFVaughtJL1994Topiramate: preclinical evaluation of structurally novel anticonvulsantEpilepsia35450608156972
   PubMed Web of Science ®Google Scholar
• ShariefMViteriCBen-MenachemE1996Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsyEpilepsy Res25217248956919
   PubMed Web of Science ®Google Scholar
• ShorvonS1996Safety of topiramate: adverse events and relationship to dosingEpilepsia37S18228641242
   PubMed Web of Science ®Google Scholar
• Sousa PdaSDe Araujo FilhoGMGarzonE2005Topiramate for the treatment of juvenile myoclonic epilepsyArq Neuropsiquiatr63733716258645
   PubMed Web of Science ®Google Scholar
• TassinariCAMichelucciRChauvelP1996Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsyEpilepsia3776388764816
   PubMed Web of Science ®Google Scholar
• TatumWOTFrenchJAFaughtE2001Postmarketing experience with topiramate and cognitionEpilepsia4211344011580760
   PubMed Web of Science ®Google Scholar
• ThijsJVerhelstHVan CosterR2001Retrospective study of topiramate in a paediatric population with intractable epilepsy showing promising effects in the West Syndrome patientsActa Neurol Belg101171611817266
   PubMed Web of Science ®Google Scholar
• TowneARGarnettLKWaterhouseEJ2003The use of topiramate in refractory status epilepticusNeurology60332412552056
   PubMed Web of Science ®Google Scholar
• ValenciaIFonsCKothareSV2005Efficacy and tolerability of topiramate in children younger than 2 years oldJ Child Neurol20667916225812
   PubMed Web of Science ®Google Scholar
• WaughJGoaKL2003Topiramate: as monotherapy in newly diagnosed epilepsyCNS Drugs179859214533950
   PubMed Web of Science ®Google Scholar
• WauquierAZhouS1996Topiramate: a potent anticonvulsant in the amygdala-kindled ratEpilepsy Res247378796355
   PubMed Web of Science ®Google Scholar
• WhiteHSBrownSDWoodheadJH1997Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure thresholdEpilepsy Res28167799332882
   PubMed Web of Science ®Google Scholar
• WhiteHSBrownSDWoodheadJH2000Topiramate modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanismEpilepsia41Suppl 1S172010768294
   PubMed Web of Science ®Google Scholar
• WuWNHeebnerJBStreeterAJ1994Evaluation of the absorption, excretion, pharmacokinetics and metabolism of the anticonvulsant topiramate in healthy menPharmaceutical Research11S336
   Google Scholar
• ZhangXVelumianAAJonesOT2000Modulation of high-voltage-activated calcium channels in dentate granule cells by topiramateEpilepsia41S526010768302
   PubMed Web of Science ®Google Scholar